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Abstract. Background/Aim: The aim of this study was the
development of a new osteoconductivity index to determine the
bone healing capacities of bone substitute materials (BSM) on
the basis of 3D microcomputed tomographic (μ-CT) data.
Materials and Methods: Sinus biopsies were used for the
comparative analysis of the integration behavior of two
xenogeneic BSM (cerabone® and Bio-Oss®). 3D μ-CT and
data sets from histomorphometrical measurements based on
2D histological slices were used to measure the bone-material-
contact and the tissue distribution within the biopsies. The
tissue reactions to both BSM were microscopically analyzed.
Results: The 3D and 2D results of the osteoconductivity
measurements showed comparable material-bone contacts for
both BSM, but the 2D data were significantly lower. The same
results were found when tissue distribution was measured in
both groups. The histopathological analysis showed
comparative tissue reactions in both BSM. Conclusion:
Osteoconductivity index is a reliable measurement parameter
for determining the healing capacities of BSM. The observed
differences between both measurement methods could be
assigned to the resolution capacity of μ-CT data that did not
allow for a precise interface distinction between both BSM and
bone tissue. Histomorphometrical data based on histological
slides still allow for a more exact evaluation.
Insufficient bone volume still poses a common challenge for
placement of dental implants. To ensure an ideal hold of the
implant in its bony implantation bed, a sufficient bone
volume is vital. Different methods used for this purpose differ
in the localization and various other factors (1, 2). In the
maxillary region, sinus augmentation, also called sinus lift, is
a standard technique to augment the maxillary sinus’ bony
floor (1). Beside autografts, allografts and alloplastic
materials, xenogeneic materials have largely been established
as standard bone substitute material (BSM) in the field of
maxillofacial surgery and dentistry. This type of BSM is
derived from bone tissue of other species (2). The structure
of xenogeneic BSM is generally very similar to the structure
of human bone, which explains their good regenerative
properties (3-5). Prior to its application as a BSM, the bovine
bone tissue must be purified due to the potentially
immunogenic character of cells, extracellular matrix elements
and possible pathogens (5). The most widely used xenogeneic
BSM, Bio-Oss® (Geistlich Pharma AG, Wolhusen,
Switzerland) and cerabone® (botiss biomaterials GmbH,
Zossen, Germany), are based on bovine bone. Interestingly,
their purification processes differ in parts: In case of Bio-
Oss®, heat treatment of the original tissue at 300˚C is
followed by sodium hydroxide treatment (5, 6). In contrast,
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the bovine bone tissue is purified by means of a two-stage
heating process for cerabone® production (5). Temperatures
above 800˚C are followed by a sintering process at 1250˚C,
ensuring the removal of all unwanted organic components
and altering the microstructure of the material (5, 7).
Interestingly, it has been assumed that the different
temperature treatments used for purification of the bone tissue
or the bone matrix may lead to different physical properties of
both BSM (5). In this context, it has been, moreover, presumed
that the differences of the materials surface pattern lead to
changes of the molecular basis of the tissue reaction to both
BSM that induce further variations in the extent of their tissue
integration and bone regeneration (5, 8). A preclinical in vivo
study using the subcutaneous implantation model has revealed
that cerabone® induces a slightly higher extent of a material-
related foreign body response with higher numbers of
biomaterial-induced multinucleated giant cells (BMGCs) up to
60 days after implantation (5, 8). However, only few data exist
regarding the clinical consequences of these material differences
(5, 8). It has already been shown that the application of both
BSM leads to comparable values of newly built bone several
months after the clinical application of both materials (9).
However, these data are based on 2D data from single
histological slides that were histomorphometrically analyzed on
the basis of a published protocol that measures the whole
fraction of bone tissue within an implantation bed of BSM
without considering the material-specific osteoconductive
characteristics. On this basis, the objective of this study was the
development of a new “osteoconductivity index” based on
histomorphometric measurement of the surface coverage of the
granules of the two xenogeneic BSM by bone tissue, as indicator
for the extent of material-associated tissue regeneration and its
osteoconductive capacities. The new "osteoconductivity index"
should be developed on the basis of microcomputed tomographic
(μ-CT) data to easily acquire values from the whole volume of
a biopsy (3D data). For this purpose, sinus biopsies from a
previous clinical study (10) were used to develop a new ImageJ
(https://imagej.nih.gov/ij/) plug-in that allows for semi-
automated evaluation of bone-material contact. Based on the 3D
data, the comparative analysis of the integration behavior of two
xenogeneic BSM was analyzed, and was also compared to
“conventional” histomorphometric data (2D data). Furthermore,
the tissue distribution was comparatively analyzed using both
imaging processes. Finally, the tissue reactions to both bone
substitute materials were analyzed following a specialized
histopathological protocol (11-18). 
Patients and Methods
Biomaterials. Both xenogeneic biomaterials are obtained from the
femoral heads of cattle from registered slaughterhouses in Australia
and New Zealand (5). Both countries carry a negligible BSE risk,
according to the World Organization for Animal Health (OIE) (19).
In the case of the two bone substitute materials, the potentially
immunogenic constituents of the donor tissue are removed in order
to guarantee a safe healing without a rejection reaction and without
transmission of diseases (5). A first step in ensuring the quality of the
two bone substitutes is to pre-select donor animals. Furthermore,
multi-stage methods involving both chemical and physical methods
are used for the purification of the original tissue of the two bone
substitute materials (11). In case of the BSM Bio-Oss® the low
temperature treatment was performed at a temperature of ~300˚C
followed by sodium hydroxide (NaOH) treatment (5). In contrast, the
BSM cerabone® was produced by heating at temperatures of up to
1,250˚C, which is referred to as so-called sintering (5). Thus, the main
difference between the purification processes of these two materials
is the treatment with different high temperatures (5). After the
respective purification processes both BSM are sterilized and packed.
Clinical procedure and biopsy harvest. The sinus biopsies, which
were examined in the present work, were extracted from 20 patients
in the course of re-entry for dental implant insertion at the
Department of Oral and Maxillofacial Surgery of the University
Hospital Cologne (10). The study was approved by the ethics
committee of the University of Cologne and the respective local
committees of Duesseldorf and Muenster, Germany. All patients
were treated six months earlier with the two xenogeneic BSM for
the purpose of sinus floor elevation for later dental implant insertion
as follows (10): Prior to the implantation procedure, perioperative
antibiosis (Amoclav 500 mg (Hexal AG, Holzkirchen, Germany) or
Clindamycin 600 mg (Clindasaar, MIP Pharma GmbH, Blieskastel,
Germany) and oral disinfection by rinsing with chlorhexidine
solution (Chlorhexamed Fluid, 0.1% GlaxoSmithKline Consumer
Healthcare GmbH, Bühl, Germany) for 30 sec were initiated. After
local anaesthesia (Ultracain D-S, Sanofi-Aventis GmbH, Frankfurt,
Germany), sinus augmentation was performed. Directly followed to
mucoperiostal reflection, a lateral bone window was created by
means of diamond burs. After that, the Schneiderian membrane was
carefully elevated and a porcine pericardium-based collagen
membrane (Alpha Bio’s Graft®, Alpha Bio, Petach Tikva, Israel)
was applied underneath the Schneiderian membrane. The BSM
cerabone® or Bio-Oss® were randomly applied into the cavity after
rehydration in sterile saline solution and another collagen membrane
was placed on the BSM. Finally, the gingival wounds were sutured
(PGA Resorba, Resorba, Nuremberg, Germany). Following a
healing period of six months, the biopsies were harvested after
mucoperiostal reflection by means of trephine burs of 3 or 4-mm
diameter (Ustomed, Tuttlingen, Germany). After further surgical
preparation tooth implants (SPI®, Alpha Bio, Petach Tikva, Israel)
were applied and the wounds were closed by suturing.
Histomorphometric analyses
Histomorphometric measurements based on micro-computed
tomography (μCT). The sinus biopsies were scanned (100 kV, 100 μA)
using a FF20 CT micro-computed tomograph (YXLON, Hamburg,
Germany) with a detector frame rate of 3 Hz.Focus-object distance
was set to 600 nm and focus-detector distance to 100 nm for
manipulation to provide an ideal image quality. Subsequently, pixels
of the μCT images were converted into three-dimensional voxel units,
with a voxel size of 12 μm. In this manner an image stack (Figures 1
and 2) was created for each specimen that reproduced all levels of a
biopsy and was supplemented by the associated metadata including
the recording settings. The image stacks of the individual biopsies
were then used to perform histomorphometric analyses. 
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The histomorphometric analysis of the μCT data was performed
using a newly programmed macro for the program ImageJ
(https://imagej.nih.gov/ij/). The respective image stack of the μCT
data was opened and calibrated utilizing the data from the
associated metadata file in ImageJ. Subsequently, selection of the
BSM, bone and connective tissue was carried out by means of the
macro for all image stacks (Figure 3). This was achieved by a
threshold-based measurement of density disparities of the fractions
of interest. Furthermore, this separation allows for measurement of
the contact length between the BSM granules and bone tissue
("osteoconductivity index", in percent (%)) as well as the volume
fraction of BSM, newly formed bone tissue and connective tissue
(in mm3). 
Histomorphometric measurements based on histology and
histopathological evaluation. For the analysis of the biopsies based
on 2D slides and for further histopathological evaluation, the
specimens were histologically prepared as previously described (10).
In brief, the tissue samples were dehydrated by means of a series of
increasing alcohol concentrations and a xylol exposure. After that
embedding in polymethylmethacrylate (PMMA, Heraeus Kulzer,
Wehrheim, Germany) was performed, followed by the preparation of
sections with a thickness of 10-15 μm, using a rotation microtome
(SLEE, Mainz, Germany). Then, the sections were treated with
hydrogen peroxide, decalcified by formic acid and histochemically
stained using specialized dyes for bone samples, i.e., hematoxylin
and eosin (H&E), toluidine blue and Movat pentachrome and Alcian
blue, as previously described (8, 12, 20, 21). 
For histomorphometric analysis, an Axio Imager 2 microscope
(Carl Zeiss AG, Oberkochen, Germany) and the software package
Zen 2 core (Carl Zeiss Microscopy GmbH, Jena, Germany) were
used for the digitization of the histological slides and the
subsequent histomorphometric measurements (Figure 4). For
determining the osteoconductivity, the surface length of the single
BSM granules and also the length of the BSM-bone-contact were
measured. Afterwards, the osteoconductivity was calculated by
forming the quotient of the total contact area and the total granule
surface length. For calculation of the tissue distribution the area of
the entire implant area of the BSM was initially measured. Then,
the areas of the different fractions, i.e., the newly formed bone, the
remaining BSM and the connective tissue, were measured.
Furthermore, the percentage values of these fractions were
calculated by forming the quotient of the respective fraction areas
and the total implantation area.
Statistical analysis. The histomorphometric data were subjected to
an analysis of variance (ANOVA). For more detailed statistical
analysis, an LSD (least significant difference) post-hoc test was then
performed using the software GraphPad Prism (version 7.0e,
GraphPad Software Inc., La Jolla, CA, USA). Statistical differences
were found to be significant with p-values of p<0.05 (*p<0.05),
p<0.01 (**p<0.01) or p<0.001 (***p<0.001). In addition, a
Welch’s t-test was carried out for the evaluation of the contact
surfaces with bone tissue.
Results
Osteoconductivity measurements. Measurement of the BMS-
bone contact area, i.e., the measurement of the material-
related osteoconductivity index, based on μ-CT data showed
that BSM cerabone® and Bio-Oss® had comparable values;
an average of 92.72±8.77% in the cerabone® group and of
88.84±8.81% in the Bio-Oss® group (Figure 5). 
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Figure 1. Exemplary images of one level from the image stacks of the μ-CT data of a respective biopsy of (A) cerabone® or (B) Bio-Oss®. Purple
stars in A and red stars in B=BSM; yellow stars=newly formed bone tissue, green stars=connective tissue. 
Measurement of the osteoconductivity index based on the
data obtained from histological slides showed also
comparable values in both study groups (Figure 5). Mean
contact areas were 22.66±17.87% in the cerabone® group
and of 16.59±5.44% in the Bio-Oss® group (Figure 5). 
The comparison of the two different imaging methods
showed that the values derived from histological slides were
significantly lower (p<0.001) compared to the data obtained
through μ-CT (Figure 5).
Tissue distribution measurements. Measurements derived
from μ-CT data showed that the average tissue distribution
was 50.12±10.97% bone tissue, 16.12±10.11% remaining
BSM and 33.77±10,81% connective tissue in the group of
the BSM cerabone® (Figure 6). Comparable average
distributions were found in the Bio-Oss® group;
44.02±10.48% bone tissue, 18.06±12.53% remaining BSM
and of 37.92±8.28% connective tissue (Figure 6). No
significant differences between the different values in the
two groups were found. 
Furthermore, the histomorphometrical measurements based
on histological slides showed that the average tissue distribution
was 20.4±8.22% bone tissue, 29.82±11.75% residual BSM and
49.78±10.37% connective tissue in the cerabone® group (Figure
6). In the BSM Bio-Oss® group, the average tissue distribution
23.95±8.89% bone tissue, 23.47±8.26% remaining BSM and
52.57±3, 89% connective tissue (Figure 6). Also, no significant
differences were identified between the values in the two study
groups (Figure 6).
However, significantly lower amounts of newly formed
bone tissue (p<0.001) were found through the analysis of the
histological slides compared to μ-CT data in both study
groups (Figure 6). Furthermore, a significantly lower amount
of remaining BSM (p<0.001) was found in the case of the
BSM cerabone® using μ-CT data compared to the data
obtained using conventional histomorphometry, while no
differences were calculated between the μ-CT and
histomorphometry data in the Bio-Oss® group (Figure 6).
Moreover, the amount of connective tissue measured via
histomorphometry were significantly higher (p<0.001) than
the values measured via μ-CT in both groups (Figure 6).
Histopathological investigations of tissue reactions. The
histopathological examinations of the tissue responses to the
two xenogeneic BSM revealed that the granules of both BSM
were predominantly surrounded by newly formed bone tissue
(Figure 7A and B). Often only thin layers of newly built bone
matrix with already embedded osteocytes as well as active
osteoblasts could be detected on the granule surfaces in both
study groups, which indicated the active process of bone
growth (Figure 7A-D). Altogether, no visible differences in
bony integration between the two BSM could be observed. 
in vivo 33: 2169-2180 (2019)
2172
Figure 2. Exemplary reconstruction of a biopsy including the BSM cerabone®. (A) 2D overview of the biopsy. (B) and (C) 3D reconstruction of the
biopsy. Green double arrows: implantation area; yellow double arrows: residual bone; purple stars: xenogeneic BSM; yellow stars: newly formed
bone, green stars: connective tissue.
Moreover, the histopathological investigation of material-
induced inflammatory tissue responses showed that almost
exclusively mononuclear cells of the macrophage lineage
were found on the granule surfaces that were adjacent to
connective tissue in the group of the BSM cerabone® (Figure
7E). Within the adjacent connective tissue slightly increased
amounts of inflammatory cells, i.e., mainly macrophages
beside lower amounts of granulocytes and a variety of
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Figure 3. Exemplary images of one level of a μ-CT image stack showing the implantation site of cerabone® with different regions of interest (ROI).
(A) ROI of the contact surface between the BSM granules and the newly formed bone tissue. (B) ROI of the BSM granules. (C) ROI of the total
implantation area (each marked by a yellow line).
Figure 4. Histopathology and histomorphometric measurements. (A) Exemplary total scan of a sinus biopsy before histomorphometry. (B)
Histomorphometrical measurement of the area of the remaining BSM (red lines) (both images: toluidine blue staining, “total scans”, ×100
magnification, scale bars=500 μm). 
fibroblasts, were observed in this study group (Figure 7E).
In the group of the BSM Bio-Oss®, several biomaterial-
associated multinucleated giant cells were found at the
material surfaces in addition to mononuclear cells, which
were mainly assigned to the macrophage line (Figure 7D and
F). In some areas the presence of circular collagen fibers
surrounding the BSM granules suggested a slight fibrotic
reaction (Figure 7D and F). Within the adjacent connective
tissue an inflammatory tissue reaction with numerous
macrophages and granulocytes next to significantly lower
amounts of fibroblasts was observed (Figure 7D and F).
Discussion
The tissue of origin of natural BSM must be purified prior
to application in order to guarantee a safe clinical
application. In some cases, purification processes and thus
purification results show considerable variation (5). The two
most widely used BSM Bio-Oss® and cerabone® are of
bovine origin and their purification processes mainly differ
with regard to temperature treatment (5). Bio-Oss® is treated
with a strong alkaline sodium hydroxide solution after a
temperature treatment of 300˚C and is thus not sintered (5).
In contrast, cerabone® is sintered at high temperatures of
around 1200˚C (5). These different temperature treatments
are presumed to influence the physical and chemical
properties of BSM, which should, therefore, lead to
variations of the material-associated inflammatory tissue
reactions as well as the healing process and osteoconductive
bone growth (5). 
In this context, it has been revealed that the inflammatory
tissue response to a biomaterial is initiated by the attachment
of proteins. The composition of this initial protein layer is
dependent on the physical properties of the material such as
surface texture as well as its chemical nature, i.e., the sum
of the physicochemical characteristics of the biomaterial
(22). Overall, the protein layer on the surface of a
biomaterial is thus a material-specific component of the
inflammation cascade that develops after its implantation
(22). Dependent on the attached proteins and their respective
conformation, cell binding sites are exposed which in each
case cause specific cellular inflammatory reactions through
signal transduction (22). In the subsequent phase, notably
macrophages are induced to express a specific range of
cytokines, which depends on the binding to the material-
specific protein binding sites (22, 23). Based on the varying
expression of pro- and anti-inflammatory cytokines
important parameters such as implant bed vascularization
and material-associated bone healing processes are
influenced (5, 22). Moreover, different amounts of
biomaterial-associated multinucleated giant cells (BMGCs)
are induced, which have been shown to be involved in tissue
in vivo 33: 2169-2180 (2019)
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Figure 6. Results of the histomorphometrical analyses of the tissue
distribution in the groups of the BSM cerabone® and Bio-Oss® assessed
through μ-CT and histological slide analysis.
Figure 5. Results of the histomorphometrical analyses of the BSM-bone
contact areas as basis of the newly developed osteoconductivity index
in the groups of the BSM cerabone® and Bio-Oss® assessed through
μ-CT and histological slide analysis.
reaction comparable to their mononuclear precursors by
expression of molecules such as the heme oxygenase-1
(HO-1), the mannose receptor (MR, also known as CD206)
and the vascular endothelial growth factor, besides, pro-
inflammatory signaling molecules (17, 24).
Based on the temperature treatments of the two above-
described xenogeneic BSM and previously published
preclinical data it has been suggested that their clinical
application might lead to different healing outcomes (5, 8).
These preclinical studies revealed substantial differences in
the material-induced inflammatory tissue responses due to
the differential surface textures of Bio-Oss® and cerabone®
(3, 5, 6, 8). In the primary phase after implantation
cerabone® showed a higher bioactivity together with higher
numbers of multinucleated giant cells compared to Bio-
Oss®, combined with a higher implant bed vascularization.
However, previous clinical studies have already shown that
comparable levels of new bone formation were found for
both BSM (9). Interestingly, comparable levels of bone
healing were also measured in the present study, which
shows that the described material differences may not have
major influence onto the final clinical success of a BSM. 
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Figure 7. Tissue integration and cellular responses to the two BSM. A, C, E: Cerabone® (CB) and B, D, F: Bio-Oss® (BO). BT: Bone tissue; CT:
connective tissue; black stars: areas of active bone formation with signs of active osteoblasts; red arrows: blood vessels; green arrows: walled
osteocytes surrounded by pre-calcified bone matrix; red stars: bone matrix margins on the granule surfaces; black arrows: mononuclear cells on
the material surface; black arrowheads: material-associated multinucleated giant cells. (A: Movat’s pentachrome staining, B: toluidine staining, A
and B: ×200-magnification, scale bar=50 μm, C-E: toluidine staining, F: Movat’s pentachrome staining, ×400-magnification, scale bars=20 μm).
However, the healing capacities of BSM have often been
determined through the histomorphometrical analysis using
2D histological slides from an implantation bed. As also
presumed in different other studies, the measurement of the
whole bone fraction in a histological slide might not reflect
the extent of osteoconductivity by a BSM (25). Thus, it has
been hypothesized that the analysis of the BSM-bone-contact
based on 3D data such as μ-CT data provides a more reliable
measurement for the regenerative potential of a bone substitute
based on its osteoconductive properties. Therefore, the main
focus of this study was to develop a novel “osteoconductivity
index” based on μ-CT data, which will reflect the material-
associated bone healing process within the entire implantation
area of a BSM. For this measurement a new macro for the
scientific freeware ImageJ was programmed. To substantiate
the reliability of the new osteoconductivity index, also
“conventional” histomorphometry of histological slides using
previously described methods was conducted (8, 12, 20, 26). 
Interestingly, the results of these measurements, based on
the two different imaging techniques, showed that the μ-CT-
based values were significantly higher (92.72±8.77% for
cerabone® and 88.84±8.81% for Bio-Oss®) compared with
the data obtained via the histology-based 2D measurements
(22.66±17.87% for cerabone® and 16.59±5.44% for Bio-
Oss®) although no differences were found comparing the
material-related data of both groups. Thus, the contact
surfaces measured by the two imaging methods differed
substantially and did not correlate with each other. Based on
the significant differences, it could be concluded that the
values obtained by one of the imaging techniques are
inaccurate. On one hand, these discrepancies in the values of
the imaging techniques can be explained by the fact that only
one layer of a biopsy was examined in the case of
histomorphometry, while μ-CT provides thorough in-depth
analyses .This means that individual biopsy parts such as the
parts of the biopsies that are within the defect may differ
immensely from the parts that are in the periphery of the
defect. As a result, the extent of bony healing measured on
basis of the histological slides could be contorted and, thus,
may not reflect the state of bone growth within the whole
implantation bed. However, in combination with the
histopathological data, which revealed that in most biopsies
the material granules in both groups were not completely
covered by newly formed bone tissue, it can be concluded
that the values that are based on the μ-CT-based
measurements are inaccurate. Moreover, it has already been
shown that the osseointegration of most BSM is nearly
complete after 6 months up to the center and the upper
border of an implantation bed after sinus augmentation (12,
20). Based on these findings, it can be assumed that the
values measured on the basis of the histologies are more
appropriate than those obtained via μ-CT data. A further
reason for this difference can be the differential resolution
or selectivity of the two methods. This means that the higher
surface contact of the BSM determined by μ-CT analysis
derived from lower selectivity of the different fractions based
on similar gray values of the natural BSM and the newly
formed bone. In this case, the μ-CT-based solution interprets
the borders of the granules as newly formed bone tissue,
which leads to distortion of the data. In this context, it should
be mentioned that both BSM were obtained from bovine
bone tissue, whose purified bone matrix and its similarity to
the human bone matrix might be the reason for the similarity
of their gray scales. Therefore, conventional histology-based
analysis regarding the development of an osteoconductivity
index should be preferred to μ-CT-based methodology.
Although different studies have confirmed the compliance of
histology-based and μ-CT-based bone tissue measurements
and also the analyses of bone-implant contact (27-29), the
present study involving both xenogeneic BSM did not allow
for a μ-CT-based examination of the target structure. To
overcome this issue the use of improved analyzers with
significantly higher resolutions in the nanometer range, so-
called nano-CT devices with resolutions of 50 nm (30), may
allow acquisition of better results with higher selectivity
between the different parts within a biopsy compared to
conventional μ-CT devices with resolutions of about 6 μm
(31). Based on the present methods and results, subsequent
studies are already planned to allow for further comparison
and validation of the present data.
Another result of the present study was the comparative
measurement of the percentages of the tissue fractions within
the biopsies. Interestingly, also for the tissue distribution
measurements, a clear difference was observed between the
data obtained by μ-CT and histology. These differences may
be due to inhomogeneous healing of the defect area with
newly formed bone and connective tissue, since the amounts
of the contained BSM are the most comparable fractions.
The lack of selectivity regarding tissue distribution
measurements may be neglected since the majority of BSM
was easily detected and analyzed and not only the interface
area. Interestingly, these results were comparable to a study
conducted by Müller et al. (27) that also has revealed a
correlation between the two methods. In contrast,
Chackartchi et al. have not identified any correlation
between 2D and 3D methods (25). Thus, additional studies
should optimize or further validate the measurement
accuracy of the two methods. 
A comparison with the literature regarding the values of
tissue distribution showed that the tissue distribution values in
case of cerabone® were comparable to those from another
clinical study, which were calculated on the basis of
histological slides (12). In one of these studies, Tawil et al.
have also applied cerabone® for 5-6 months for the purpose of
sinus augmentation and they have shown  values of
22.77±5.89% of newly formed bone, 34.9±7.10% of remaining
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BSM and 42.29±8.98% of connective tissue (12). Moreover,
different studies have shown comparable tissue fractions values
after clinical application of the BSM Bio-Oss® (5, 32, 33). For
example, in the study by Yong-Moo Lee et al. tissue
distributions were 18.3±5.4% newly formed bone tissue,
29.8±8.8% remaining BSM, and 52.0±6, 6% connective tissue
for Bio-Oss® (34). Thus, these results also correspond to the
data obtained by conventional histomorphometry
measurements in the present work and can hence confirm the
comparability and validity of this histomorphometric
measurement method. Especially, it should be emphasized that
no differences in osteoconductivity or tissue distribution were
found for the two BSM by the histology-based or the μ-CT-
based data. These results are of particular importance as they
show that the application of both xenogeneic BSM leads to
comparable extents of osteoconductive bone growth. These
results are furthermore substantiated by other studies such as
an examination by Panagiotou et al. that have also revealed
comparable results with no significant differences in osseous
regeneration between Bio-Oss® and cerabone® after 8 months
(9). These data lead to the conclusion that the previously
described different material characteristics have no influence
on bony healing. 
In addition, the tissue reactions to the two xenogeneic
BSM were analyzed by histopathological evaluation
following a previously published protocol (12). The analysis
showed that Bio-Oss®and cerabone® were integrated into
newly formed bone tissue to a large part without visible
differences between τηεμ. Furthermore, the investigation of
material-induced inflammatory tissue responses showed that
cerabone® induced a slight inflammatory tissue reaction
mostly involving cells of the macrophage lineage and only
very low numbers of biomaterial-associated multinucleated
giant cells (BMGCs). In contrast, in the group of BSM Bio-
Oss®, higher numbers of BMGCs were found at the material
surfaces in addition to macrophages combined with the
presence of circular collagen fibers, which seems to be a
slight fibrotic reaction. No differences in the implantation
bed vascularization were observed between the study groups.
These results are in line with various other studies that have
analyzed the osteoconductive integration behavior and the
biocompatibility of both BSM (8, 34-38)). Interestingly, also
previous preclinical and clinical studies have revealed
differences of the (initial) tissue reactions to the two BSM,
mainly due to different numbers of BMGCs and different
implant bed vascularization (5). Interestingly, it was
observed that cerabone® induced higher numbers of BMGCs
and a higher implant bed vascularization, which was
assumed to be due to the afore-mentioned different
characteristics of the two biomaterials (5). However, higher
numbers of BMGCs were found in case of Bio-Oss® in the
present study obviously without influence onto the overall
bone regeneration process. These results lead to the
conclusion that the initially observed tissue reactions may
have subsided and fallen to a comparable level after a period
of up to 6 months. Consequently, it can be deduced that
initially different tissue reactions have no influence on long-
term reaction to BSM. The results of the present study
further showed that the material-related inflammatory tissue
response was still detectable for both BSM, but can be
classified as very low, similar to the findings of Barbeck et
al. who have observed a decrease of inflammation to a low
level after an initially strong tissue response to Bio-Oss® (8).  
In summary, it can be concluded that there is no difference
in bony healing mediated by the two investigated xenogeneic
BSM – the osteoconductivity covered material surfaces and
the bone volume – after several months of healing.
Furthermore, similar tissue reactions indicate that differences
in the methods of preparing the donor tissue have no long-
term influences on tissue reactions and material-assisted
bony healing. Thus, both materials serve as biocompatible
and osteoconductive scaffolds without undergoing significant
degradation.
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